Indian pharmaceutical company Strides Pharma Science Ltd said on Thursday it has got regulatory approval to conduct clinical trials of antiviral drug favipiravir, considered a potential treatment for COVID-19.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/3e2G0ao
